phosphotyrosine has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, GM; Baguley, TD; Brouillette, J; Chatterjee, M; Cuny, GD; Ellman, JA; Foscue, E; Ghosh, D; Glicksman, MA; Greengard, P; Gresack, J; Kanyo, J; Kurup, P; Lam, TT; Lombroso, PJ; Nairn, AC; Ononenyi, C; Seyb, K; Tautz, L; Xu, J; Zhang, Y | 1 |
| Bruno, MA; Burgess, K; Clarke, PB; Cuello, AC; Quirion, R; Saragovi, HU; Seltzer, A | 1 |
2 other study(ies) available for phosphotyrosine and Cognition Disorders
| Article | Year |
|---|---|
Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amino Acid Sequence; Animals; Benzothiepins; Catalytic Domain; Cell Death; Cerebral Cortex; Cognition Disorders; Cysteine; Disease Models, Animal; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Neurons; Phosphorylation; Phosphotyrosine; Protein Tyrosine Phosphatases, Non-Receptor; Substrate Specificity | 2014 |
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA.
Topics: Acetylcholine; Aging; Animals; Basal Nucleus of Meynert; Biotinylation; Cerebral Cortex; Choline O-Acetyltransferase; Cholinergic Fibers; Cognition Disorders; Drug Evaluation; Injections, Intraventricular; Male; Maze Learning; Memory Disorders; Microscopy, Confocal; Nerve Growth Factor; Nerve Tissue Proteins; Nootropic Agents; Peptides, Cyclic; Phenotype; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Rats; Rats, Inbred F344; Receptor, trkA | 2004 |